FDG PET/CT Imaging of Oropharyngeal Squamous Cell Carcinoma
Tóm tắt
Từ khóa
Tài liệu tham khảo
Chaturvedi, 2011, Human papillomavirus and rising oropharyngeal cancer incidence in the United States., J Clin Oncol, 29, 4294, 10.1200/JCO.2011.36.4596
Smith, 2004, Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers., Int J Cancer, 108, 766, 10.1002/ijc.11633
DSouza, 2007, Case-control study of human papillomavirus and oropharyngeal cancer., N Engl J Med, 356, 1944, 10.1056/NEJMoa065497
Subramaniam, 2010, Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer., AJNR Am J Neuroradiol, 31, 598, 10.3174/ajnr.A1760
Isles, 2008, A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy., Clin Otolaryngol, 33, 210, 10.1111/j.1749-4486.2008.01688.x
Davison, 2010, Squamous cell carcinoma of the palatine tonsils: FDG standardized uptake value ratio as a biomarker to differentiate tonsillar carcinoma from physiologic uptake., Radiology, 255, 578, 10.1148/radiol.10091479
Imsande, 2011, Use of 18F-FDG PETCT as a predictive biomarker of outcome in patients with head-and-neck non-squamous cell carcinoma., AJR Am J Roentgenol, 197, 976, 10.2214/AJR.10.4884
Paidpally, 2012, FDG-PETCT imaging biomarkers in head and neck squamous cell carcinoma., Imaging Med, 4, 633, 10.2217/iim.12.60
Lok, 2012, Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes., Int J Radiat Oncol Biol Phys, 82, 1851, 10.1016/j.ijrobp.2011.03.029
Chung, 2009, Metabolic tumor volumes by 18F-fluorodeoxyglucose PETCT correlate with occult metastasis in oral squamous cell carcinoma of the tongue., Ann Surg Oncol, 16, 3111, 10.1245/s10434-009-0621-3
Dibble, 2012, 18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging., J Nucl Med, 53, 709, 10.2967/jnumed.111.099531
Chung, 2009, Metabolic tumor volume of 18F-fluorodeoxyglucose positron emission tomographycomputed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer., Clin Cancer Res, 15, 5861, 10.1158/1078-0432.CCR-08-3290
La, 2009, Metabolic tumor volume predicts for recurrence and death in head and neck cancer., Int J Radiat Oncol Biol Phys, 74, 1335, 10.1016/j.ijrobp.2008.10.060
Salamon, 2013, Evaluation of intratumoural heterogeneity on (18)F-FDG PETCT for characterization of peripheral nerve sheath tumours in neurofibromatosis type 1., Eur J Nucl Med Mol Imaging, 40, 685, 10.1007/s00259-012-2314-6
Fakhry, 2008, Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial., J Natl Cancer Inst, 100, 261, 10.1093/jnci/djn011
Koch, 2012, Clinical features of HPV-related head and neck squamous cell carcinoma: presentation and work-up., Otolaryngol Clin North Am, 45, 779, 10.1016/j.otc.2012.04.004
Ang, 2010, Human papillomavirus and survival of patients with oropharyngeal cancer., N Engl J Med, 363, 24, 10.1056/NEJMoa0912217
Goldenberg, 2008, Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon., Head Neck, 30, 898, 10.1002/hed.20796
Lassen, 2011, The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 67 trial., Radiother Oncol, 100, 49, 10.1016/j.radonc.2011.02.010
DSouza, 2010, Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer., Oral Oncol, 46, 100, 10.1016/j.oraloncology.2009.11.004
Romesser, 2012, Superior prognostic utility of gross and metabolic tumor volume compared to standardized uptake value using PETCT in head and neck squamous cell carcinoma patients treated with intensity-modulated radiotherapy., Ann Nucl Med, 26, 527, 10.1007/s12149-012-0604-5
Schwartz, 2004, FDG-PET prediction of head and neck squamous cell cancer outcomes., Arch Otolaryngol Head Neck Surg, 130, 1361, 10.1001/archotol.130.12.1361
Torizuka, 2009, Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer., AJR Am J Roentgenol, 192, W156, 10.2214/AJR.08.1429
Machtay, 2009, Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer., Head Neck, 31, 195, 10.1002/hed.20942
Lim, 2012, 18F-FDG PETCT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma., J Nucl Med, 53, 1506, 10.2967/jnumed.111.101402